4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001314596-26-000002
Director sold 15,481 shares at $8.28 ($128,183)
- Director acquired 25,344 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Katkin Keith Director | 2026-04-30 | Grant or award 10b5-1 | +25,344 | 111,775 | D | ||
| Katkin Keith Director | 2026-04-30 | Sale 10b5-1 | −15,481 | $8.28 | $128,183 | 96,294 | D |
| Derivatives | |||||||
| Katkin Keith Director | 2026-04-30 | Grant or award · Stock Options (Right to Buy) 10b5-1 | +11,296 | 11,296 | D | ||
| Open-market sales · 15,481 sh · avg $8.28 · $128,183 | |||||||
Loading xslF345X06/wk-form4_1777930168.xml…